Arecor Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	24	30	25	56	69	92
Market Cap Growth	22.12%	23.66%	-56.02%	-19.53%	-24.62%	-
Enterprise Value	17.94	24.36	21.55	49.47	56.93	74.05
Last Close Price	0.63	0.81	0.74	1.83	2.40	4.00
PE Ratio	31.75	40.25	-	-	-	-
PS Ratio	13.99	17.73	14.96	12.22	28.90	79.56
PB Ratio	3.71	4.71	4.59	5.87	3.98	4.97
P/TBV Ratio	3.87	4.93	4.62	8.97	4.94	4.97
EV/Sales Ratio	10.47	14.21	13.12	10.82	23.69	63.95
EV/EBITDA Ratio	15.64	21.24	-	-	-	-
EV/EBIT Ratio	19.25	26.14	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	0.09	0.09	-	-	-	-
Net Debt / Equity Ratio	-0.93	-0.93	-0.57	-0.67	-0.72	-0.97
Net Debt / EBITDA Ratio	-5.26	-5.26	0.63	0.74	1.23	2.89
Net Debt / FCF Ratio	1.90	1.90	0.53	1.07	1.13	3.28
Asset Turnover	0.20	0.20	0.14	0.25	0.11	0.09
Inventory Turnover	1.87	1.87	1.16	3.49	0	-
Quick Ratio	4.78	4.78	2.38	2.02	4.38	9.05
Current Ratio	4.78	4.78	2.53	2.17	4.69	9.05
Return on Equity (ROE)	15.79%	15.79%	-69.41%	-63.41%	-51.44%	-63.85%
Return on Assets (ROA)	10.39%	10.39%	-43.55%	-47.48%	-43.75%	-45.38%
Return on Invested Capital (ROIC)	207.08%	63.65%	-193.02%	-219.06%	-345.79%	-3417.98%
Return on Capital Employed (ROCE)	15.59%	15.59%	-65.97%	-64.92%	-57.30%	-59.82%
Earnings Yield	2.77%	2.48%	-	-	-	-
Buyback Yield / Dilution	-23.11%	-17.94%	-9.20%	-5.83%	-25.63%	-41.77%
Total Shareholder Return	-23.11%	-17.94%	-9.20%	-5.83%	-25.63%	-41.77%